DiogenX SAThe French biotech company DiogenX is further strengthening its management team. In November, Dr Klara Owen was appointed as Chief Medical Officer.
Innate PharmaFrench Innate Pharma SA announced the appointment of Jonathan Dickinson as the Company’s newChief Executive Officer (CEO) and Chairman of the Executive Board. He succeeds Hervé Brailly, co-founder of the Company, who was interim CEO, during the search process.
AAX BiotechSwedish biotech company AAX Biotech AB has welcomed Patrik Strömberg as a new member of the Board of Directors.
Jean-Marie Huron for DiogenXThe biotech company DiogenX, based in Marseille (F), has appointed Hélène Sicard, PhD, as Chief Development Officer.
AstoriomLori A. Ball has been appointed as the new Chief Executive Officer of UK-based Astoriom. She will be responsible for driving the development of Astoriom’s sample management business in the US, UK and Europe.
Mogrify LtdCambridge-based Mogrify Ltd announces the appointment of Dr. Jonathan Appleby as Chief Scientific Officer.
A new Chief Business Officer strengthens the management team of Macomics Ltd (UK). Simon Drew took over the newly created position in June.
At the end of May, Dr Uwe Meya took over as Chief Medical Officer at Oxford-based SynaptixBio.
In November 2023, Enhanc3D Genomics appointed Dr Hazel Jones as interim CEO and COO. Now she has taken over the Position of CEO officially.
Dublin-based ERS Genomics Ltd appointed John E Milad as CEO in the middle of May. He took over from Erik Rhodes, CEO for the last eight years.